Pre-Exposure Prophylaxis HIV during Pandemic Covid-19: Challenge and Strategy

References (38)

1. 1 Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal [DOI]
2. 2 Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework [DOI]
3. 3 Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models [DOI]
4. 4 Effect of pandemic based online education on teaching and learning system [DOI]
5. 5 Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review [DOI]
6. 6 Healthcare Workers’ Burdens During the COVID-19 Pandemic: A Qualitative Systematic Review [DOI]
7. 7 Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations [DOI]
8. 8 Integrating HIV services and other health services: A systematic review and meta-analysis [DOI]
9. 9 Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers [DOI]
10. 10 Preparations for and practices of online education during the Covid-19 pandemic: A study of Bangladesh and Nepal [DOI]
11. 11 Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior [DOI]
12. 12 Ensuring Access to Medications in the US During the COVID-19 Pandemic [DOI]
13. 13 Attitudes Toward HIV Pre-Exposure Prophylaxis Among Men Who Have Sex with Men in Western China [DOI]
14. 14 Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil [DOI]
15. 15 Estimated Lifetime HIV–Related Medical Costs in the United States [DOI]
16. 16 The COVID-19 Pandemic and the US Health Care Workforce [DOI]
17. 17 High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil [DOI]
18. 18 PrEP acceptability and initiation among women engaged in sex work in Uganda: Implications for HIV prevention [DOI]
19. 19 Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa [DOI]
20. 20 Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials [DOI]
21. 21 Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda [DOI]
22. 22 Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment [DOI]
23. 23 Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients [DOI]
24. 24 Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study [DOI]
25. 25 Evaluating the implementation of home delivery of medication by community health workers during the COVID-19 pandemic in Cape Town, South Africa: a convergent mixed methods study [DOI]
26. 26 “The Drug Will Help Protect My Tomorrow”: Perceptions of Integrating PrEP into HIV Prevention Behaviors Among Female Sex Workers in Lilongwe, Malawi [DOI]
27. 27 Impact of the early 2020 COVID-19 crisis and lockdown on PrEP use among men who have sex with men (MSM) in France [DOI]
28. 28 Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision [DOI]
29. 29 Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study [DOI]
30. 30 Condom failure and pre-exposure prophylaxis use experience among female sex workers in Ethiopia: a qualitative study [DOI]
31. 31 Determinants of Opportunistic Infections Among HIV-Positive Patients on HAART in Debre Berhan Referral Hospital, North Shoa Zone, Ethiopia, 2020: A Case–Control Study [DOI]
32. 32 Implementation and effectiveness of drive-through medication pick-up and home delivery services. A patient safety initiative during COVID-19 pandemic [DOI]
33. 33 Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries [DOI]
34. 34 Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics [DOI]
35. 35 Prevalence and determinants of opportunistic infections in HIV patients: A cross-sectional study in the city of Semarang [DOI]
36. 36 Home delivery of medications: Community pharmacists' perspectives on the pros and cons of the service [DOI]
37. 37 Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms? [DOI]
38. 38 Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe [DOI]

Cited by 0

No indexed citations yet.

Related research

• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
• Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
• Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
• Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage